John Joseph Stephens
John Joseph Stephens's purchase track record
How the stock did after each of John Joseph Stephens's open-market purchases, measured from the purchase date. Several fills within a week count as one purchase.
| Purchase | Stock | Amount | 3 months | 6 months | S&P 500, 6 mo. |
|---|---|---|---|---|---|
| 3/10/2023 | SLDP | $626K | -31.5% | -27.8% | +15.4% |
| 8/30/2022 | SLDP | $204K | -35.1% | -48.9% | -0.4% |
| 8/17/2022 | SLDP | $378K | -30.5% | -47.0% | -3.0% |
Computed by MarketWall from SEC Form 4 filings and daily closing prices (close on the purchase date to the close about 3 and 6 months later). Companies that have since delisted are not included. Past results, not investment advice.
Associated companies
Synthesized from recent news and fundamentals/technical data -- not human analyst commentary or trader sentiment.
September 25, 2026
Quantum startup names New Mexico native as CEO. A recent report notes that a quantum startup has appointed a New Mexico native as its chief executive officer. This news appears unrelated to Solid Power Inc., which focuses on solid-state battery technology for electric vehicles. There are no new company-specific updates for SLDP in the provided data.
Transaction History
| FCX | ▲ Buy | Grant | 294 | $21K | 10/1/2026 | View on chart |
| FCX | ▲ Buy | Grant | 327 | $21K | 7/1/2026 | View on chart |
| FCX | ▲ Buy | Grant | 2,800 | $0 | 6/1/2026 | View on chart |
| SLDP | ▲ Buy | Grant | 44,133 | $0 | 5/20/2026 | View on chart |
| FCX | ▲ Buy | Grant | 350 | $21K | 4/1/2026 | View on chart |
| FCX | ▲ Buy | Grant | 406 | $21K | 1/1/2026 | View on chart |
| FCX | ▲ Buy | Grant | 525 | $21K | 10/1/2025 | View on chart |
| FCX | ▲ Buy | Grant | 475 | $21K | 7/1/2025 | View on chart |
| FCX | ▲ Buy | Grant | 4,900 | $0 | 6/1/2025 | View on chart |
| SLDP | ▲ Buy | Grant | 118,808 | $0 | 5/21/2025 | View on chart |
| FCX | ▲ Buy | Grant | 561 | $21K | 4/1/2025 | View on chart |
| FCX | ▲ Buy | Grant | 525 | $20K | 1/1/2025 | View on chart |
| FCX | ▲ Buy | Grant | 400 | $20K | 10/1/2024 | View on chart |
| FCX | ▲ Buy | Grant | 411 | $20K | 7/1/2024 | View on chart |
| FCX | ▲ Buy | Grant | 3,500 | $0 | 6/1/2024 | View on chart |
| SLDP | ▲ Buy | Grant | 82,365 | $0 | 5/22/2024 | View on chart |
| FCX | ▲ Buy | Grant | 451 | $21K | 4/1/2024 | View on chart |
| FCX | ▲ Buy | Grant | 440 | $19K | 1/1/2024 | View on chart |
| FCX | ▲ Buy | Grant | 502 | $19K | 10/1/2023 | View on chart |
| FCX | ▲ Buy | Grant | 468 | $19K | 7/1/2023 | View on chart |
| FCX | ▲ Buy | Grant | 5,000 | $0 | 6/1/2023 | View on chart |
| SLDP | ▲ Buy | Grant | 59,197 | $0 | 5/24/2023 | View on chart |
| FCX | ▲ Buy | Grant | 458 | $19K | 4/1/2023 | View on chart |
| SLDP | ▲ Buy | Open Market | 214,500 | $626K | 3/10/2023 | View on chart |
| FCX | ▲ Buy | Grant | 493 | $19K | 1/1/2023 | View on chart |
| FCX | ▲ Buy | Grant | 686 | $19K | 10/1/2022 | View on chart |
| SLDP | ▲ Buy | Open Market | 30,000 | $204K | 8/30/2022 | View on chart |
| SLDP | ▲ Buy | Open Market | 25,000 | $163K | 8/23/2022 | View on chart |
| SLDP | ▲ Buy | Open Market | 17,289 | $123K | 8/18/2022 | View on chart |
| SLDP | ▲ Buy | Open Market | 13,216 | $91K | 8/17/2022 | View on chart |
| FCX | ▲ Buy | Grant | 640 | $19K | 7/1/2022 | View on chart |
| FCX | ▲ Buy | Grant | 4,500 | $0 | 6/1/2022 | View on chart |
| SLDP | ▲ Buy | Grant | 15,700 | $0 | 5/25/2022 | View on chart |
| FCX | ▲ Buy | Grant | 376 | $19K | 4/1/2022 | View on chart |
| FCX | ▲ Buy | Grant | 449 | $19K | 1/1/2022 | View on chart |
| FCX | ▲ Buy | Grant | 576 | $19K | 10/1/2021 | View on chart |
AI Market Commentary
AI-generatedAll commentary →Synthesized from recent news and fundamentals/technical data -- not human analyst commentary or trader sentiment.
October 17, 2026
FCX Grasberg on schedule amid cash flow valuation questions
Recent news highlights that Freeport-McMoRan's Grasberg operation is back on schedule, supporting its production outlook. However, market commentary questions whether the stock is priced for perfection on cash flow, with copper prices acting as a key test. The company's valuation of 33.9 times trailing earnings reflects high market expectations for cash flow delivery.
FCX Grasberg on schedule amid cash flow valuation questions. Recent news highlights that Freeport-McMoRan's Grasberg operation is back on schedule, supporting its production outlook. However, market commentary questions whether the stock is priced for perfection on cash flow, with copper prices acting as a key test. The company's valuation of 33.9 times trailing earnings reflects high market expectations for cash flow delivery.